Why Kinaxis (TSX:KXS) Is a Buy After its Impressive Q2 Earnings

Despite its high valuation, Kinaxis is a buy. Here’s why.

| More on:

Kinaxis (TSX:KXS) provides supply chain management solutions for its customers. Over the last five years, it has created significant wealth for its shareholders by delivering over 1,270% of returns. Even this year, when the broader equity markets are trading lower amid the pandemic, the company’s stock price has more than doubled.

Last week, Kinaxis had reported impressive second-quarter earnings outperforming analysts’ expectations. Let’s look at its second-quarter performance in more detail.

Strong year-over-year- growth

During the second quarter, Kinaxis’s revenue grew 45% year over year to US$61.4 million, which outperformed analysts’ expectations by 17.3%. The growth in the sales of its SaaS (software-as-a-service) segment, subscription term licence segment, and the professional services segment drove the company’s revenue.

New customer acquisition and the expansion of the existing customer subscriptions contributed to the company’s revenue growth. Amid the pandemic, the company’s employees worked remotely, supporting the company’s existing customers and aided in the deployment of software for the new customers.

Meanwhile, the addition of new employees and the acquisition of Prana in the first quarter contributed to the revenue growth from its professional services segment.

During the quarter, Kinaxis’s adjusted EBITDA increased by over 94% due to its top-line growth and expansion in gross margin. The margins on the subscription term licence segment are on the higher side. So, the increase of over 300% in the segment’s revenue improved the company’s gross margins also. Meanwhile, higher operating expenses offset some of the gains in its EBITDA.

Liquidity and valuation

Kinaxis generated US$30.8 million of cash from its operations in the second quarter, raising its cash and cash equivalents to US$260.6 million. Meanwhile, subsequent to the quarter, the company completed the acquisition of Rubikloud, utilizing US$60 million of its cash. So, after the acquisition, the company’s cash and cash equivalent stood at roughly US$200 million.

Currently, Kinaxis trades at a premium. Its forward price-to-earnings multiple stands at 118.1, while its average for the past three years stands at 57.5. Also, it trades at a forward EV-to-sales multiple of 16.2 compared to the industry average of 4.1 times. Although the company’s valuation multiples look expensive, I believe the strong growth prospects justify these high valuations.

Outlook

Amid uncertainty due to the pandemic, many companies have withdrawn their guidance for this fiscal quarter. However, Kinaxis has hiked its overall revenue guidance for this fiscal, while maintaining its guidance for the adjusted EBITDA margin.

The management expects its revenue to come in the range of US$216-US$220 million compared to US$191.5 million in 2019. Meanwhile, its adjusted EBITDA margin could come in between 20% and 23%.

Kinaxis has a strong sales pipeline with backlog revenue standing at US$333 million at the end of the second quarter. Over the next few years, the company would recognize these sales after delivering the required service. Also, the acquisition of Rubikloud, which provides artificial intelligence software for retailers, could boost its sales. So, I believe the company’s outlook looks robust.

Bottom line

Amid the pandemic, it’s not just large online retailers going online; even small and medium retailers are going online. This shift towards e-commerce could put pressure on many companies’ supply chains due to the need for quicker fulfillment time, competitive pricing, and flexibility. So, I believe this could raise the demand for Kinaxis services going forward.

So, despite its expensive valuation, I believe investors should buy Kinaxis, given its long-term growth potential.

Should you invest $1,000 in Bausch Health Companies right now?

Before you buy stock in Bausch Health Companies, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Bausch Health Companies wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends KINAXIS INC.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Tech Stocks

Income and growth financial chart
Tech Stocks

2 Canadian Stocks That Could Turn $10,000 Into $100,000

If you're looking for growth and income, these two are some of the best options out there.

Read more »

money goes up and down in balance
Tech Stocks

1 Magnificent Tech Stock Down 27% to Buy and Hold Forever

Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) is starting to look severely undervalued after its latest drop!

Read more »

ways to boost income
Tech Stocks

1 Undervalued TSX Stock Down 18% to Buy and Hold

This TSX stock remains down but is due for a huge comeback for investors.

Read more »

grow money, wealth build
Tech Stocks

This TSX Stock Down 20% Could Triple Your Money by 2028

Down 20% from its 52-week high, this TSX stock is positioned to more than triple investor returns over the next…

Read more »

money goes up and down in balance
Tech Stocks

The Smartest Canadian Stock to Buy With $600 Right Now

The Canadian stock market has some big winners trading at discounted share prices, ripe for the taking, and here’s one…

Read more »

Muscles Drawn On Black board
Dividend Stocks

The Best Canadian Stocks to Buy Right Away With $4,000

Seeking strength from your investments? Then these are the three stocks to consider first.

Read more »

Investor wonders if it's safe to buy stocks now
Tech Stocks

Where Will BlackBerry Be in 4 Years?

With fresh partnerships and a tighter focus, BlackBerry is trying to lay the foundation for long-term growth.

Read more »

Start line on the highway
Tech Stocks

The Smartest Canadian Stock to Buy With $10,000 Right Now

Investors interested in tech can consider Constellation Software.

Read more »